Bacterial eradication in the treatment of otitis media

被引:45
作者
Dagan, R
Leibovitz, E
机构
[1] Soroka Univ Med Ctr, Pediat Infect Dis Unit, IL-84101 Beer Sheva, Israel
[2] Ben Gurion Univ Negev, Fac Hlth Sci, IL-84105 Beer Sheva, Israel
关键词
D O I
10.1016/S1473-3099(02)00394-8
中图分类号
R51 [传染病];
学科分类号
100401 ;
摘要
Drugs differ in their ability to eradicate various pathogens from the middle-ear cavity during acute otitis media (AOM), and these differences clearly affect clinical outcome. Outcome is derived from differences in the association between concentrations of the drugs at the site of infection and the antimicrobial effect (termed pharmacodynamics). These differences are even more marked in the present era of antimicrobial resistance. However, since AOM Dose Time is a self-limiting disease in most cases, difference in clinical outcome is more difficult to ascertain than that of bacteriological outcome, which is measured within 3-5 days. A favourable clinical outcome regardless of the bacteriological effect of the drug can result in false optimism when less-effective antibiotic drugs are used. Inappropriate study design and manipulation of clinical results add to this confusion. In this review we attempt to highlight the evidence regarding bacteriological response to antibiotics in AOM and to draw attention to potential flaws that may mislead clinicians.
引用
收藏
页码:593 / 604
页数:12
相关论文
共 92 条
[1]   STREPTOCOCCUS-PNEUMONIAE - VIRULENCE FACTORS, PATHOGENESIS, AND VACCINES [J].
ALONSODEVELASCO, E ;
VERHEUL, AFM ;
VERHOEF, J ;
SNIPPE, H .
MICROBIOLOGICAL REVIEWS, 1995, 59 (04) :591-&
[2]   ANTIMICROBIAL RESISTANCE IN STREPTOCOCCUS-PNEUMONIAE - AN OVERVIEW [J].
APPELBAUM, PC .
CLINICAL INFECTIOUS DISEASES, 1992, 15 (01) :77-83
[3]   CO-AMOXICLAV IN RECURRENT ACUTE OTITIS-MEDIA - PLACEBO CONTROLLED-STUDY [J].
APPELMAN, CLM ;
CLAESSEN, JQPJ ;
TOUWOTTEN, FWMM ;
HORDIJK, GJ ;
DEMELKER, RA .
BMJ-BRITISH MEDICAL JOURNAL, 1991, 303 (6815) :1450-1452
[4]   A REVIEW OF ANTIBIOTIC-RESISTANCE PATTERNS OF STREPTOCOCCUS-PNEUMONIAE IN EUROPE [J].
BAQUERO, F ;
MARTINEZBELTRAN, J ;
LOZA, E .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1991, 28 :31-38
[5]   DO CHILDREN WITH RECURRENT HEMOPHILUS-INFLUENZAE OTITIS-MEDIA BECOME INFECTED WITH A NEW ORGANISM OR REACQUIRE THE ORIGINAL STRAIN [J].
BARENKAMP, SJ ;
SHURIN, PA ;
MARCHANT, CD ;
KARASIC, RB ;
PELTON, SI ;
HOWIE, VM ;
GRANOFF, DM .
JOURNAL OF PEDIATRICS, 1984, 105 (04) :533-537
[6]   UNUSUAL MANIFESTATIONS OF PNEUMOCOCCAL INFECTION IN HUMAN-IMMUNODEFICIENCY-VIRUS INFECTED INDIVIDUALS - THE PAST REVISITED [J].
BARRADAS, MCR ;
MUSHER, DM ;
HAMILL, RJ ;
DOWELL, M ;
BAGWELL, JT ;
SANDERS, CV .
CLINICAL INFECTIOUS DISEASES, 1992, 14 (01) :192-199
[7]   CURRENT CONCEPTS - OTITIS-MEDIA IN CHILDREN [J].
BERMAN, S .
NEW ENGLAND JOURNAL OF MEDICINE, 1995, 332 (23) :1560-1565
[8]   Cytology of middle ear fluid during acute otitis media [J].
Broides, A ;
Leibovitz, E ;
Dagan, R ;
Press, J ;
Raiz, S ;
Kafka, M ;
Lieberman, A ;
Yermiahu, T .
PEDIATRIC INFECTIOUS DISEASE JOURNAL, 2002, 21 (01) :57-60
[9]   HOST FACTORS AND EARLY THERAPEUTIC RESPONSE IN ACUTE OTITIS-MEDIA [J].
CARLIN, SA ;
MARCHANT, CD ;
SHURIN, PA ;
JOHNSON, CE ;
SUPER, DM ;
REHMUS, JM .
JOURNAL OF PEDIATRICS, 1991, 118 (02) :178-183
[10]   EARLY RECURRENCES OF OTITIS-MEDIA - REINFECTION OR RELAPSE [J].
CARLIN, SA ;
MARCHANT, CD ;
SHURIN, PA ;
JOHNSON, CE ;
MURDELLPANEK, D ;
BARENKAMP, SJ .
JOURNAL OF PEDIATRICS, 1987, 110 (01) :20-25